Chronic Anal Fissures Clinical Trial
Official title:
A Phase 3B, Randomized, Double-Blind, Placebo-Controlled, Parallel-Treatment Group, Multicenter Efficacy and Safety Study of Topical Diltiazem Hydrochloride 2% Cream in Subjects With Anal Fissure
The purpose of this study is to determine if the study drug, VEN307 (diltiazem hydrochloride cream) is safe and to see if it will help with treatment of pain associated with anal fissures.
Primary Objective:
To evaluate the efficacy of diltiazem hydrochloride cream on reduction of worst anal fissure
(AF)-related pain associated with or following defecation when administered three times a day
(TID) for 28 days.
;